Le Lézard
Classified in: Health
Subjects: PDT, SCZ

September AARP Bulletin: Marijuana and Your Health

WASHINGTON, Sept. 4, 2019 /PRNewswire/ -- A patchwork of state and federal laws and an unprecedented marking blitz have left many older Americans with questions about medical marijuana and cannabidiol (CBD). In an AARP Bulletin special report, experts explain where marijuana is legal, if it is safe to use and the many forms in which it is sold. The feature also includes a comprehensive review of which health conditions cannabis has proven to provide relief or lacks scientific support. Plus, a report on the effectiveness of CBD oils, which have taken the wellness market by storm in the past year. Discover the surprising truths, myths and realities of medical marijuana in the September issue of AARP Bulletin.

AARP national logo. (PRNewsfoto/AARP)

Additionally, AARP investigates issues surrounding the 2020 census, the first in U.S. history that will be primarily digital. Given how many government programs will be funded based on the 2020 census maps, it is crucially important that older Americans know their options, participate online or via paper form in the mail and get counted. Find out why the 2020 census matters to you and your community.

Other stories in the September issue:

Fraud Watch

Your Money

Your Health

Your Life

More information can be found at: http://www.aarp.org/bulletin/

About AARP
AARP is the nation's largest nonprofit, nonpartisan organization dedicated to empowering people 50 and older to choose how they live as they age. With a nationwide presence and nearly 38 million members, AARP strengthens communities and advocates for what matters most to families: health security, financial stability and personal fulfillment. AARP also produces the nation's largest circulation publications: AARP The Magazine and AARP Bulletin. To learn more, visit www.aarp.org or follow @AARP and @AARPadvocates on social media.



These press releases may also interest you

at 23:00
The Montreal Heart Institute (MHI) announced today that the COLCORONA clinical trial has provided clinically persuasive results of colchicine's efficacy to treat COVID-19. The study results have shown that colchicine has reduced by 21% the risk of...

at 23:00
The Alisal Guest Ranch and Resort has partnered with biosafety company R-Zero, incorporating the company's hospital-grade UV-C technology into its disinfection protocols to ensure a safe reopening for guests and staff amid the COVID-19 pandemic. The...

at 21:25
The Lupus Research Alliance (LRA) is excited to share that the U.S. Food and Drug Administration (FDA) approved the use of Aurinia Pharmaceuticals' LupkynisTM (voclosporin) as the first oral treatment developed specifically for adults with active...

at 21:12
For the second time in less than two months, the U.S. Food and Drug Administration (FDA) has approved a new medication to treat adults with lupus nephritis (lupus-related kidney disease) in combination with a background immunosuppressive therapy...

at 20:25
Aurinia Pharmaceuticals Inc. ("Aurinia" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has approved LUPKYNISTM (voclosporin) in combination with a background immunosuppressive therapy regimen to treat adult...

at 19:46
Clover Leaf Seafoods Corp. is recalling Clover Leaf brand Sardines Boneless Fillets - Garlic & Chive in Oil and Sardines Boneless Fillets - Smoked Jalapeño in Oil from the marketplace because they may permit the growth of Clostridium botulinum....

News published on 4 september 2019 at 11:48 and distributed by: